\-\ Texto\\:\\ \ \(0\)\
\-\ left\\ nasal\\ mass\\.\ \(0\)\
\-\ surgery\\ only\\ to\\ date\\.\\ \\ no\\ radiation\\ or\\ chemotherapy\\ anticipated\\.\ \(0\)\
\-\ erosive\\ mass\\ extending\\ from\\ left\\ side\\ of\\ nose\\ into\\ ethmoid\\ sinus\\ and\\ penetrating\\ into\\ the\\ anterior\\ cranial\\ fossa\\.\\ \\ mass\\ enhances\\ following\\ contrast\\ administration\\ and\\ is\\ associated\\ with\\ a\\ mild\\ degree\\ of\\ brain\\ edema\\.\ \(0\)\
\-\ nasal\\ malignant\\ peripheral\\ nerve\\ sheath\\ tumor\\ \\(mpnst\\)\ \(0\)\
\-\ esthenioneuroblastoma\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ fungal\\ infection\ \(12\)\
\-\ 64\\ year\\ old\\ renal\\ transplant\\ patient\\ evaluated\\ for\\ nasal\\ fullness\\ on\\ the\\ left\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nasal\\:\\ 0\\.42435673848950123\ \(0\)\
\-\ esthenioneuroblastoma\\:\\ 0\\.2481279500107494\ \(0\)\
\-\ mpnst\\:\\ 0\\.22927469502500572\ \(0\)\
\-\ anticipated\\:\\ 0\\.21042144003926205\ \(0\)\
\-\ mass\\:\\ 0\\.17779615564747264\ \(0\)\
\-\ into\\:\\ 0\\.16495633669439566\ \(0\)\
\-\ erosive\\:\\ 0\\.1646784519559406\ \(0\)\
\-\ penetrating\\:\\ 0\\.16344189822714383\ \(0\)\
\-\ ethmoid\\:\\ 0\\.16225912503484546\ \(0\)\
\-\ left\\:\\ 0\\.15878111289038785\ \(0\)\
\-\ fullness\\:\\ 0\\.1579837561531067\ \(0\)\
\-\ nose\\:\\ 0\\.15701224225564722\ \(0\)\
\-\ transplant\\:\\ 0\\.15516750171794946\ \(0\)\
\-\ sheath\\:\\ 0\\.15429002247758275\ \(0\)\
\-\ 64\\:\\ 0\\.14582519697019694\ \(0\)\
\-\ date\\:\\ 0\\.1434058700491018\ \(0\)\
\-\ fungal\\:\\ 0\\.13888435018901205\ \(0\)\
\-\ enhances\\:\\ 0\\.13676383543885073\ \(0\)\
\-\ degree\\:\\ 0\\.1356534977020727\ \(0\)\
\-\ evaluated\\:\\ 0\\.13257101441249775\ \(0\)\
\-\ cranial\\:\\ 0\\.1268142632966504\ \(0\)\
\-\ administration\\:\\ 0\\.12355826683059429\ \(0\)\
\-\ fossa\\:\\ 0\\.12180285148803097\ \(0\)\
\-\ sinus\\:\\ 0\\.1121145520777665\ \(0\)\
\-\ peripheral\\:\\ 0\\.11094932129012172\ \(0\)\
\-\ nerve\\:\\ 0\\.11068736583865173\ \(0\)\
\-\ malignant\\:\\ 0\\.11060060500759913\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.11017090416754331\ \(0\)\
\-\ side\\:\\ 0\\.10718604143129157\ \(0\)\
\-\ extending\\:\\ 0\\.10519764234164994\ \(0\)\
\-\ radiation\\:\\ 0\\.10281914302692853\ \(0\)\
\-\ only\\:\\ 0\\.09693256112771252\ \(0\)\
\-\ brain\\:\\ 0\\.09672373478545396\ \(0\)\
\-\ renal\\:\\ 0\\.09661991978357373\ \(0\)\
\-\ infection\\:\\ 0\\.09372309931367881\ \(0\)\
\-\ following\\:\\ 0\\.09307874944390973\ \(0\)\
\-\ edema\\:\\ 0\\.09253834430073235\ \(0\)\
\-\ mild\\:\\ 0\\.08795342886693347\ \(0\)\
\-\ anterior\\:\\ 0\\.08662994900745061\ \(0\)\
\-\ metastatic\\:\\ 0\\.08509521131817711\ \(0\)\
\-\ surgery\\:\\ 0\\.08341833674166227\ \(0\)\
\-\ associated\\:\\ 0\\.08177875760130039\ \(0\)\
\-\ tumor\\:\\ 0\\.08115550125732264\ \(0\)\
\-\ contrast\\:\\ 0\\.07538705001052876\ \(0\)\
\-\ disease\\:\\ 0\\.06512890556413628\ \(0\)\
\-\ and\\:\\ 0\\.06412210548950872\ \(0\)\
\-\ the\\:\\ 0\\.061918420289785656\ \(0\)\
\-\ from\\:\\ 0\\.06162131783108741\ \(0\)\
\-\ of\\:\\ 0\\.0607266184351034\ \(0\)\
\-\ or\\:\\ 0\\.05397595056240065\ \(0\)\
\-\ patient\\:\\ 0\\.05046440256479897\ \(0\)\
\-\ no\\:\\ 0\\.05045491050486228\ \(0\)\
\-\ year\\:\\ 0\\.047815972110045755\ \(0\)\
\-\ for\\:\\ 0\\.04702654136198234\ \(0\)\
\-\ on\\:\\ 0\\.046859723927259275\ \(0\)\
\-\ old\\:\\ 0\\.04591988513515152\ \(0\)\
\-\ is\\:\\ 0\\.0424904782297975\ \(0\)\
\-\ to\\:\\ 0\\.03878865277704751\ \(0\)\
\-\ with\\:\\ 0\\.03038145128757401\ \(0\)\
